Skip to main content

Carbon reduction planning

Build the baseline before publishing the reduction

NEUVIOR’s carbon reduction approach begins with a defined reporting boundary, evidenced activity data and a method that can be reviewed before targets or reductions are presented publicly.

Document position | Planning frameworkCurrent evidence | No unsupported reduction percentagePublication gate | Baseline and method required

Baseline first

A reduction cannot be understood without a starting point.

The reporting entity, period, emission sources and calculation method must be defined before a carbon reduction can be claimed.

Where reliable data is unavailable, the gap should be recorded rather than filled with an estimate presented as fact.

01

Boundary

Identify the company activities, sites, suppliers and services included.

Required
02

Period

Choose a reporting period supported by complete and reviewable records.

Required
03

Method

Document calculation factors, assumptions and material exclusions.

Required

Planning cycle

Measure, prioritise, act and review.

Carbon planning should focus first on the material activities the company can influence and the evidence needed to judge progress.

01

Measure

Collect activity data and retain the source record.

01
02

Prioritise

Identify material sources and realistic areas for change.

02
03

Act

Assign an accountable owner and a defined intervention.

03
04

Review

Compare like with like and explain any change in scope or method.

04

Publication boundary

Targets and outcomes require different evidence.

A target is future intent. A measured result is a historical claim. Neither should be presented without its status, scope and review date.

Human decision requiredProceed only inside an evidenced and governed scope.
01

Baseline

Publish only when the source data and method can be explained.

Current evidence
02

Target

State the future date, scope, assumptions and accountable owner.

Future intent
03

Outcome

Report only after the period closes and the result can be checked.

Historical evidence

Make the next step useful

Bring the problem that needs a clearer decision.

Tell us what is stuck, what decision you need to make and what a better outcome would change. We will connect you to the most relevant NEUVIOR, PHARMORIS, media or investor route.

QUESTIONS · ANSWERED DIRECTLY

The useful answers, in one place.

Browse every question
01What is NEUVIOR?

NEUVIOR is a pharmaceutical company registered in Scotland. It is building capabilities across medicines intelligence, governed technology and longer term development. PHARMORIS is its immediate product priority.

02What does NEUVIOR build today?

NEUVIOR is developing PHARMORIS, a human-governed medicines operations system in controlled, non-production development. It is intended to connect evidence, decisions, accountable work and value review. No independent TRL, deployment, customer adoption or clinical validation is claimed.

03What is PHARMORIS by NEUVIOR?

PHARMORIS is a configurable medicines operations system under controlled development. It is designed to help authorised teams progress medicine opportunities from evidence linked to its source, through an owned ActionCase, a human decision, delivery and review.

04Who founded NEUVIOR?

Varun Sharma is the Founder, CEO and CTO of NEUVIOR and leads the company and PHARMORIS product architecture.

05Where does NEUVIOR have a presence?

NEUVIOR works across Glasgow, London and Mumbai. Glasgow is the company origin and registered Scottish base. London supports commercial activity led by the founder. Mumbai supports market engagement in India and relationships across the pharmaceutical sector. These are different forms of presence. They do not imply three registered offices or regulated facilities.